AAAAAA
Results:
1-12
|
Results: 12
Authors:
Fonseca, R
Oken, MM
Harrington, D
Bailey, RJ
Van Wier, SA
Henderson, KJ
Kay, NE
Van Ness, B
Greipp, PR
Dewald, GW
Citation: R. Fonseca et al., Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy, LEUKEMIA, 15(6), 2001, pp. 981-986
Authors:
Kay, NE
Jelinek, DF
Peterson, LA
Citation: Ne. Kay et al., Angiogenesis in B-chronic lymphocytic leukemia, LEUK RES, 25(8), 2001, pp. 709-710
Authors:
Kay, NE
Jelinek, DF
Peterson, L
Citation: Ne. Kay et al., Angiogenesis in B-chronic lymphocytic leukemia, LEUK RES, 25(6), 2001, pp. 485-486
Authors:
Hogan, WJ
Kay, NE
Citation: Wj. Hogan et Ne. Kay, 87-year-old man with macrocytic anemia, MAYO CLIN P, 76(2), 2001, pp. 201-204
Authors:
Kay, NE
Han, L
Bone, N
Williams, G
Citation: Ne. Kay et al., Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8(+) T cells from B-CLL patients: impact on clonal B-cell apoptosis, BR J HAEM, 112(3), 2001, pp. 760-767
Authors:
Kay, NE
Leong, TL
Bone, N
Vesole, DH
Greipp, PR
Van Ness, B
Oken, MM
Kyle, RA
Citation: Ne. Kay et al., Blood levels of immune cells predict survival in myeloma patients: resultsof an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosedmultiple myeloma patients, BLOOD, 98(1), 2001, pp. 23-28
Authors:
Kini, AR
Kay, NE
Peterson, LC
Citation: Ar. Kini et al., Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia, LEUKEMIA, 14(8), 2000, pp. 1414-1418
Authors:
Fonseca, R
Trendle, MC
Leong, T
Kyle, RA
Oken, MM
Kay, NE
Van Ness, B
Greipp, PR
Citation: R. Fonseca et al., Prognostic value of serum markers of bone metabolism in untreated multiplemyeloma patients, BR J HAEM, 109(1), 2000, pp. 24-29
Authors:
Greipp, PR
Trendle, MC
Leong, T
Oken, MM
Kay, NE
Van Ness, B
Kyle, RA
Citation: Pr. Greipp et al., Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?, LEUK LYMPH, 35(1-2), 1999, pp. 83-89
Authors:
Trendle, MC
Leong, T
Kyle, RA
Katzmann, JA
Oken, MM
Kay, NE
Van Ness, BG
Greipp, PR
Citation: Mc. Trendle et al., Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (clg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486, AM J HEMAT, 61(4), 1999, pp. 232-237
Authors:
Mu, XY
Gosland, MP
Bartik, MM
Schimmelpfennig, J
Kay, NE
Citation: Xy. Mu et al., Activation of human peripheral blood T cells does not lead to increased P-glycoprotein expression, J CLIN IMM, 19(4), 1999, pp. 239-246
Authors:
Oken, MM
Leong, T
Lenhard, RE
Greipp, PR
Kay, NE
Van Ness, B
Keimowitz, RM
Kyle, RA
Citation: Mm. Oken et al., The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma - Phase III Eastern Cooperative Oncology Group clinical trial EST 9486, CANCER, 86(6), 1999, pp. 957-968
Risultati:
1-12
|